Apolipoprotein E and Alzheimer's Disease

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  2000-02-01

• Fields of study

  Biology, Medicine, History

• Identifiers
  DOI 10.1111/j.1749-6632.2000.tb05565.xPMID 11193808
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Cellular senescence and the blood–brain barrier: Implications for aging and age-related diseases

  2023cites this paper
• Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer’s Disease drug candidate

  2023cites this paper
• Neural correlates of subjective cognitive decline in adults at high risk for Alzheimer’s disease

  2023cites this paper
• Peripheral metabolism of lipoprotein-amyloid beta as a risk factor for Alzheimer’s disease: potential interactive effects of APOE genotype with dietary fats

  2023cites this paper
• Regular proton pump inhibitor use and incident dementia: population-based cohort study

  2022cites this paper
• Intertwined relationship among ROS, mitochondria and APOE4 during the onset of Alzheimer's disease

  2022cites this paper
• Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study

  2022cites this paper
• Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease

  2022cites this paper
• Pore Formation Mechanism of A-Beta Peptide on the Fluid Membrane: A Combined Coarse-Grained and All-Atomic Model

  2022cites this paper
• Crosstalk between neurological, cardiovascular, and lifestyle disorders: insulin and lipoproteins in the lead role

  2022cites this paper
• An AS‐qPCR‐based method for the detection of Alzheimer's disease‐related SNPs

  2022influential citation
• Apolipoprotein E in Cardiometabolic and Neurological Health and Diseases

  2022cites this paper
• Synaptic degeneration in Alzheimer disease

  2022cites this paper
• High-density lipoprotein in Alzheimer's disease: From potential biomarkers to therapeutics.

  2021cites this paper
• Recurring Gastrointestinal Infections Increase the Risk of Dementia

  2021influential citation
• The Protective Role of Exercise Against Age-Related Neurodegeneration.

  2021cites this paper
• Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria.

  2021cites this paper
• Indoles as essential mediators in the gut-brain axis. Their role in Alzheimer's disease.

  2021cites this paper
• Real-world Evaluation of Tolerability, Safety and Efficacy of Rivastigmine Oral Solution in Patients with Mild to Moderate Alzheimer’s Disease Dementia

  2021cites this paper
• Neurodegenerative Disease: Roles for Sex, Hormones, and Oxidative Stress.

  2021cites this paper
• Microglia, TREM2, and Therapeutic Methods of Alzheimer’s Disease

  2021cites this paper
• Post-hoc analysis of single nucleotide polymorphism profile for eyes with vascularized pigment epithelial detachment due to ARMD

  2020cites this paper
• Apolipoprotein E4 exhibits intermediates with domain interaction.

  2020cites this paper
• The Effect of the APOE ε2ε4 Genotype on the Development of Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) in Non‐Latino Whites

  2020cites this paper
• Inherited risk of dementia and the progression of cerebral small vessel disease and inflammatory markers in cognitively healthy midlife adults: the PREVENT-Dementia study

  2020cites this paper
• Shared signaling pathways in Alzheimer’s and metabolic disease may point to new treatment approaches

  2020cites this paper
• Interaction between tissue transglutaminase and amyloid-beta: Protein-protein binding versus enzymatic crosslinking.

  2020cites this paper
• Influence of APOE genotype in primary age-related tauopathy

  2020cites this paper
• Klinische Neurogenetik: DNA-Diagnostik und Beratungsaspekte

  2020cites this paper
• Influence of APOE Genotype on Mortality and Cognitive Impairment

  2020cites this paper
• Expanding the Phenotype of Frontotemporal Lobar Degeneration With FUS-Positive Pathology (FTLD-FUS).

  2020cites this paper
• Emerging Therapeutic Promise of Ketogenic Diet to Attenuate Neuropathological Alterations in Alzheimer’s Disease

  2020cites this paper
• When time's arrow doesn't bend: APOE-ε4 influences episodic memory before old age.

  2019cites this paper
• Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality.

  2019cites this paper
• Isolation housing exacerbates Alzheimer’s Disease phenotype in aged APP KI mice

  2019cites this paper
• Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer's disease patients with APOE4-/-: A double-blind, randomized, placebo-controlled crossover trial.

  2019cites this paper
• ApoE4 Exacerbates Hippocampal Pathology Following Acute Brain Penetration Injury in Female Mice

  2019cites this paper
• ApoE4: an emerging therapeutic target for Alzheimer’s disease

  2019cites this paper
• Antisense Oligonucleotides for Treatment of Neurological Diseases

  2018cites this paper
• Characterizing the Effects of Sex, APOE ɛ4, and Literacy on Mid-life Cognitive Trajectories: Application of Information-Theoretic Model Averaging and Multi-model Inference Techniques to the Wisconsin Registry for Alzheimer’s Prevention Study

  2018cites this paper
• Thymoquinone activates MAPK pathway in hippocampus of streptozotocin-treated rat model.

  2018cites this paper
• Hétérogénéité génétique de la maladie d’Alzheimer : des mutations causales aux facteurs de risque génétiques rares et fréquents

  2017cites this paper
• Translational Research: Preclinical to Healthy Volunteer to Patient

  2017cites this paper
• Dissociation of Neuropathologic Findings and Cognition

  2016cites this paper
• Voxel-based morphometry to detect effect of APOE on brain gray matter changes in Parkinson's Disease.

  2016cites this paper
• Genetic Influences in Traumatic Brain Injury

  2016cites this paper
• The Aging Mind in Transition: Amyloid Deposition and Progression toward Alzheimer's Disease

  2016cites this paper
• A new mathematical modeling for pure parsimony haplotyping problem.

  2016cites this paper
• Pathological Consequences of Aβ From Extracellular to Intraneuronal

  2016cites this paper
• Allen Roses, MD, Who Identified Risk-Gene for Alzheimerʼs Disease, Dies

  2016cites this paper
• Physiological and pathophysiological functions of cell cycle proteins in post-mitotic neurons: implications for Alzheimer’s disease

  2015cites this paper
• Inorganic Mercury and Alzheimer’s Disease—Results of a Review and a Molecular Mechanism

  2015cites this paper
• Diagnosis, Management, and Treatment of Alzheimer Disease

  2015cites this paper
• Potensi Terapi Hormon Testosteron terhadap Ekspresi β Amyloid pada Marmut sebagai Model Penyakit Alzheimer

  2014cites this paper
• HDL and cognition in neurodegenerative disorders.

  2014cites this paper
• Butyrylcholinesterase K and apolipoprotein ε4 affect cortical thickness and neuropsychiatric symptoms in Alzheimer's disease.

  2014cites this paper
• Investigação de associação entre a Butirilcolinesterase e a doença de Alzheimer

  2014cites this paper
• Mercury toxicity and neurodegenerative effects.

  2014cites this paper
• Accurate zygote-specific discrimination of single-nucleotide polymorphisms using microfluidic electrochemical DNA melting curves.

  2014cites this paper
• The novel role of the neuropeptides orexin and QRFP and their involvement in Alzheimer's disease

  2014cites this paper
• Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis

  2014cites this paper
• Vitamin E-gene interactions in aging and inflammatory age-related diseases: implications for treatment. A systematic review.

  2014cites this paper
• The involvement of lipids in Alzheimer's disease.

  2014cites this paper
• Genome Analysis and Human Health: A Critical Appraisal

  2013cites this paper
• Association of sleep disordered breathing and cognitive deficit in APOE ε4 carriers.

  2013cites this paper
• ApoE ε4 is associated with eIF2α phosphorylation and impaired learning in young mice.

  2013cites this paper
• Effect of Lifestyle, Aging, and Phytochemicals on the Onset of Neurological Disorders

  2013cites this paper
• Lipid Metabolism in Neurodegenerative Diseases

  2012cites this paper
• A personalized life: biomarker monitoring from cradle to grave.

  2012cites this paper
• Do tocotrienols have potential as neuroprotective dietary factors?

  2012cites this paper
• The Amyloid _-Protein and Alzheimer's Disease

  2012cites this paper
• A large study reveals no association between APOE and Parkinson's disease.

  2012cites this paper
• Galantamine: an update

  2011cites this paper
• Selenium in Alzheimer’s Disease

  2011cites this paper
• Heparan Sulfate in the Amyloidosis and Inflammation of Alzheimer’s Disease

  2011cites this paper
• Redox proteomics and drug development.

  2011cites this paper
• A influência genética sobre a memória humana: uma revisão

  2011cites this paper
• Molecular and expression analysis of apolipoprotein E gene in the Chinese sturgeon, Acipenser sinensis.

  2011cites this paper
• Ubiquilin-1 Is a Molecular Chaperone for the Amyloid Precursor Protein*

  2011cites this paper
• The Neuropathology of the Dementing Disorders

  2011cites this paper
• Identification of the regulatory mechanisms and factors involved in the brain-specific expression of CYP46A1

  2010cites this paper
• Current research status, databases and application of single nucleotide polymorphism.

  2010cites this paper
• Analysis of association between bleomycin hydrolase and apolipoprotein E polymorphism in Alzheimer’s disease

  2010cites this paper
• Review Article Neuropathology of non-Alzheimer degenerative disorders

  2010cites this paper
• Genetic Determinants of Cognitive Function and Age-Related Brain Changes

  2010cites this paper
• Genetic and Blood Biomarkers of Alzheimer's Disease

  2010cites this paper
• Neuronal cholesterol esterification by ACAT1 in Alzheimer's disease

  2010cites this paper
• Amyloid β-protein, Cystatin C and Cathepsin B as Biomarkers of Alzheimer's Disease

  2010cites this paper
• MOLECULAR GENETICS OF EARLY

  2010cites this paper
• Externalizing disorders: Cluster 5 of the proposed meta-structure for DSM-V and ICD-11

  2009cites this paper
• Neurocognitive disorders: Cluster 1 of the proposed meta-structure for DSM-V and ICD-11

  2009cites this paper
• About the role of the apolipoprotein E4 polymorphism in dementia : does genetic testing have a place in the assessment of Alzheimer's disease?

  2009cites this paper
• Methodological Approaches to Study the Genetics of Dementia and Cognitive Function

  2009cites this paper
• Lipid metabolism and Alzheimer's disease: pathways and possibilities

  2009cites this paper
• Alzheimer’s Disease and Other Neurodegenerative Disorders

  2009cites this paper
• Die Alzheimer‐Demenz: von der Pathologie zu therapeutischen Ansätzen

  2009cites this paper
• Decoding the Genetics and Underlying Mechanisms of Mood Disorders Sevilla D. Detera-Wadleigh and Takeo Yoshikawa

  2009cites this paper
• ALZHEIMER'S DISEASE AND DEMENTIAS

  2009cites this paper
• Die genetische und funktionelle Bedeutung des High Temperature Requirement A1 Proteins (HtrA1) und eines HtrA1-Single Nucleotide Polymorphismus für Morbus Alzheimer

  2009cites this paper
• Apolipoprotein status and cognitive functioning in adulthood: role of physical health and social network characteristics

  2009cites this paper